Eingabehilfen | Sitemap | Kontaktieren Sie uns | Service-Hotline 0800/7833524
Deutschland Change Country
Startseite  |  Einsatzgebiete  |  Produkte  |  Klinische Evidenz  |  Fortbildung & Training  |  Für Patienten  |  Kundendienst
Sie sind hier Startseite > Nachrichten & Medien > Neues vom Unternehmen > KCI Announces Agreement with 3M Health Care
Drucken

KCI Announces Agreement with 3M Health Care

Freigegeben : 29 Juli 2008

SAN ANTONIO--(BUSINESS WIRE)--July 29, 2008--Kinetic Concepts, Inc. (NYSE: KCI) today announced that it has entered into an agreement with 3M Health Care for the supply of 3M™ Tegaderm™ brand transparent film dressings for inclusion in KCI kits with KCI's V.A.C.® Therapy System in the treatment of complex, hard-to-heal wounds. The newly-designed 3M™ Tegaderm™ dressing, configured exclusively for use with V.A.C.® Therapy, will provide a skin-friendly interface that conforms to the body and flexes with skin for greater patient comfort. Additionally, this dressing will be simpler for health care professionals to apply.

"We are very excited about this new relationship, which brings together two global market leaders with best-in-class technologies and brands," said Catherine M. Burzik, President and CEO of KCI. "This novel drape will be packaged with a newly designed and configured GranuFoam® dressing, which will enhance the performance and reliability of V.A.C.® Therapy, while making dressing changes even easier."

Chuck Kummeth, Vice President and General Manager, 3M Medical Division, added, "Because of the leading technologies we each bring to the market, together we are able to provide a unique solution that will help patients with hard-to-heal wounds. This collaboration reinforces 3M's commitment to improving patient outcomes."

The first V.A.C.® Therapy dressings featuring the 3M™ Tegaderm™ brand transparent film dressings are expected to be available beginning in the fourth quarter of 2008.

About KCI

Kinetic Concepts, Inc. (NYSE: KCI) is a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and can be traced to a history deeply rooted in innovation and a passion for significantly improving the healing - and the lives - of patients around the world.

KCI's three primary businesses include:

Advanced Wound Care - Includes KCI's proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System, which has been clinically demonstrated to promote wound healing through unique mechanisms of action while reducing the overall cost of treating patients with complex wounds.

Tissue Regeneration - Represented by KCI's LifeCell business and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

Therapeutic Support Systems - Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, to reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size.

The company employs 7,000 people and markets its products in more than 20 countries. For more information about KCI, and how its products are changing the practice of medicine, visit www.KCI1.com.

About 3M Health Care

3M Health Care, one of 3M's six major business segments, provides world-class innovative products and services to help health care professionals improve the practice, delivery and outcome of patient care in medical, oral care, drug delivery and health information markets.

Forward-Looking Statements

This press release contains forward-looking statements regarding the expected launch of the new products. Forward-looking statements may contain words such as believes, expects, anticipates, estimates, projects, intends, should, seeks, future, continue, or the negative of such terms, or other comparable terminology. Forward-looking statements are subject to risks, uncertainties, assumptions and other factors that are difficult to predict and that could cause actual results to vary materially from those expressed in or indicated by them. Additional risks and factors are identified in KCI's filings with the U.S. Securities Exchange Commission (the SEC), including its Annual Report on Form 10-K for the fiscal year ending December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, which are available on the SEC's Web site at http://www.sec.gov. KCI undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Source: Kinetic Concepts, Inc.

FOR MORE INFORMATION, CONTACT:

Kinetic Concepts, Inc.
Media Relations:
Media@kci1.com for journalists only.
or
Investors Relations:
IR@kci1.com for Investor Relations inquiries.

Drucken
  • Share on Facebook.com
  • Share on Twitter
  • Besuchen Sie unsere YourTube Seite